Options market data suggests increased call buying over puts. These stocks are moving-our analysis flagged them today. Act fast before the price catches up: However, an impressive consensus price target is not the only factor that indicates a potential upside in BBIO. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside. BBIO stock forecast may benefit from sector tailwinds in biotech, with healthcare expenditure projections rising globally. The company’s rare disease niche offers pricing power and reduced competitive pressure.
